Allegro Opthalmics Finds $10.7M In Funding

San Juan Capistrano-based Allegro Opthalmics, a developer of drug treaments for treating diabetic macular edema (DME) and vitreomacular traction (VMT), said today that it has raised $10.7M in an equity funding round. Source of the new funding injection was not announced. According to Allegro, the new funding goes to complete multiple Phase 2 clinical trials and prepare for Phase 3 studies. More information »